Share this post: Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email The eagerly awaited results of the FOURIER trial were recently presented at the Annual Meeting of the American College of Cardiology (ACC) in Washington DC and simultaneously published in the New England Journal of Medicine (1). The goal of FOURIER was … Continue reading Evolocumab (Repatha) for Heart Disease – The FOURIER Trial – Success or Failure?